Cargando…

Non-Motor Symptom Burdens Are Not Associated with Iron Accumulation in Early Parkinson's Disease: a Quantitative Susceptibility Mapping Study

BACKGROUND: Quantitative susceptibility mapping (QSM) has been used to measure iron accumulation in the deep nuclei of patients with Parkinson's disease (PD). This study examined the relationship between non-motor symptoms (NMSs) and iron accumulation in the deep nuclei of patients with PD. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Chaewon, Lee, Seon, Lee, Jee-Young, Rhim, Jung Hyo, Park, Sun-Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865060/ https://www.ncbi.nlm.nih.gov/pubmed/29573246 http://dx.doi.org/10.3346/jkms.2018.33.e96

Ejemplares similares

Iron deposition in Parkinson’s disease by quantitative susceptibility mapping
por: Chen, Qiqi, et al.
Publicado: (2019)

Cortical Iron Accumulation as an Imaging Marker for Neurodegeneration in Clinical Cognitive Impairment Spectrum: A Quantitative Susceptibility Mapping Study
por: Kim, Hyeong Woo, et al.
Publicado: (2023)

Quantitative Susceptibility Mapping in Parkinson's Disease
por: Langkammer, Christian, et al.
Publicado: (2016)

Quantitative susceptibility mapping in atypical Parkinsonisms
por: Mazzucchi, Sonia, et al.
Publicado: (2019)

Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia
por: Li, Darrell T.H., et al.
Publicado: (2018)

Evaluation of iron deposition in brain basal ganglia of patients with Parkinson's disease using quantitative susceptibility mapping
por: Shahmaei, Vahid, et al.
Publicado: (2019)

Time-Specific Pattern of Iron Deposition in Different Regions in Parkinson's Disease Measured by Quantitative Susceptibility Mapping
por: Fu, Xiaodi, et al.
Publicado: (2021)

Genetic impacts on nigral iron deposition in Parkinson's disease: A preliminary quantitative susceptibility mapping study
por: Wu, Jingjing, et al.
Publicado: (2023)

Non-Motor Symptoms Burden in Early Stages of Parkinson's Disease
por: Sardar, Zomer, et al.
Publicado: (2023)

Evaluation of abnormal iron distribution in specific regions in the brains of patients with Parkinson's disease using quantitative susceptibility mapping and R2(*) mapping
por: Cheng, Qingqing, et al.
Publicado: (2020)

Striatal Dopamine Depletion Patterns and Early Non-Motor Burden in Parkinsons Disease
por: Chung, Su Jin, et al.
Publicado: (2016)

Iron in Multiple Sclerosis and Its Noninvasive Imaging with Quantitative Susceptibility Mapping
por: Stüber, Carsten, et al.
Publicado: (2016)

Quantitative Susceptibility Mapping of Brain Iron Deposition in Patients With Recurrent Depression
por: Duan, Xinxiu, et al.
Publicado: (2022)

Evaluation of iron deposition in the motor CSTC loop of a Chinese family with paroxysmal kinesigenic dyskinesia using quantitative susceptibility mapping
por: Xie, Fangfang, et al.
Publicado: (2023)

Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms
por: Mazzucchi, Sonia, et al.
Publicado: (2022)

Iron deposition heterogeneity in extrapyramidal system assessed by quantitative susceptibility mapping in Parkinson’s disease patients with type 2 diabetes mellitus
por: Li, Wanyao, et al.
Publicado: (2022)

Quantitative Digitography Measures Motor Symptoms and Disease Progression in Parkinson’s Disease
por: Wilkins, Kevin B., et al.
Publicado: (2022)

Utility of quantitative susceptibility mapping and diffusion kurtosis imaging in the diagnosis of early Parkinson’s disease
por: Tan, Samantha, et al.
Publicado: (2021)

Quantitative susceptibility mapping of basal ganglia iron is associated with cognitive and motor functions that distinguish spinocerebellar ataxia type 6 and type 3
por: Marvel, Cherie L., et al.
Publicado: (2022)

Investigation of brain iron in anorexia nervosa, a quantitative susceptibility mapping study
por: Ravanfar, Parsa, et al.
Publicado: (2023)

Brain iron content in cerebral amyloid angiopathy using quantitative susceptibility mapping
por: Sharma, Breni, et al.
Publicado: (2023)

Asymmetrical nigral iron accumulation in Parkinson’s disease with motor asymmetry: an explorative, longitudinal and test-retest study
por: Guan, Xiaojun, et al.
Publicado: (2020)

Chelators in the Treatment of Iron Accumulation in Parkinson's Disease
por: Mounsey, Ross B., et al.
Publicado: (2012)

Quantitative susceptibility mapping based hybrid feature extraction for diagnosis of Parkinson's disease
por: Xiao, Bin, et al.
Publicado: (2019)

Parkinson’s disease or multiple system atrophy: potential separation by quantitative susceptibility mapping
por: Marxreiter, Franz, et al.
Publicado: (2023)

Brain Iron Deposits in Thalamus Is an Independent Factor for Depressive Symptoms Based on Quantitative Susceptibility Mapping in an Older Adults Community Population
por: Zhang, Wenhua, et al.
Publicado: (2019)

Extra-basal ganglia iron content and non-motor symptoms in drug-naïve, early Parkinson’s disease
por: Kim, Minkyeong, et al.
Publicado: (2021)

Many Faces of Parkinson’s Disease: Non-Motor Symptoms of Parkinson’s Disease
por: Lee, Hye Mi, et al.
Publicado: (2015)

Elevated Heme Oxygenase-1 Correlates With Increased Brain Iron Deposition Measured by Quantitative Susceptibility Mapping and Decreased Hemoglobin in Patients With Parkinson’s Disease
por: Xu, Jinghui, et al.
Publicado: (2021)

Combined Application of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Techniques to Investigate the Effect of Iron Deposition on Microstructural Changes in the Brain in Parkinson’s Disease
por: Yang, Lin, et al.
Publicado: (2022)

Quantitative Susceptibility Mapping Reveals an Association between Brain Iron Load and Depression Severity
por: Yao, Shun, et al.
Publicado: (2017)

Systematic Review: Quantitative Susceptibility Mapping (QSM) of Brain Iron Profile in Neurodegenerative Diseases
por: Ravanfar, Parsa, et al.
Publicado: (2021)

Brain iron assessment in patients with First-episode schizophrenia using quantitative susceptibility mapping
por: Xu, Man, et al.
Publicado: (2021)

Predicting Motor Outcome of Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease Using Quantitative Susceptibility Mapping and Radiomics: A Pilot Study
por: Liu, Yu, et al.
Publicado: (2021)

Validation of MRI quantitative susceptibility mapping of superparamagnetic iron oxide nanoparticles for hyperthermia applications in live subjects
por: Deh, Kofi, et al.
Publicado: (2020)

Non-motor symptoms burden in motor-fluctuating patients with Parkinson’s disease may be alleviated by safinamide: the VALE-SAFI study
por: De Masi, Claudia, et al.
Publicado: (2022)

Iron Accumulation Is Not Homogenous among Patients with Parkinson's Disease
por: Dashtipour, Khashayar, et al.
Publicado: (2015)

Iron accumulation in the ventral tegmental area in Parkinson's disease
por: Zhang, Dongling, et al.
Publicado: (2023)

Safinamide Improves Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study
por: Santos García, Diego, et al.
Publicado: (2021)

Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's disease
por: Cheng, Zenghui, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gm26cenmnukthcfmldbo3e22n9